EUTM file information



April 11, 2021

Trademark Summary

The trademark application BRIUMVI was filed by TG Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on April 25, 2021, and it was registered by office on August 2, 2021 without any oppositions.

The application was filed in English (German was selected as the second language).

Total Surrender of the trademark registration was recorded on October 28, 2021.

Goods And Services

  • The mark was filed in class 5 with Pharmaceutical preparations and substances for the treatment of oncological diseases and disorders.